The effect of intravenous ascorbic acid in hemodialysis patients with normoferritinemic anemia

• Egile Nagusiak: Dae Woong Kang (Egilea), Chi Yong Ahn (Egilea), Bong Kwan Ryu (Egilea), Byung Chul Shin (Egilea), Jong Hoon Chung (Egilea), Hyun Lee Kim (Egilea)
• Formatua: Liburua
• Argitaratua: The Korean Society of Nephrology, 2012-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: Hemodialysis (HD) patients with functional iron deficiency often develop resistance to recombinant human erythropoietin (rhEPO). Recent studies have shown that intravenous ascorbic acid (IVAA) administration could override rhEPO resistance in HD patients. This study was undertaken to tes...